Delivery Order SPE2DR25D2214-SPE2DR26FV9F6
- Not listed
- The Defense Logistics Agency issued a $4,244.58 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for INGREZZA 80 mg capsule 30-count units, with an ultimate completion date of March 25, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. Pricing is firm fixed...
- <p>The Defense Logistics Agency issued a $3,874.06 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for INGREZZA 40 mg capsule (30-count unit), with an ultimate completion date of March 26, 2026.</p> <p>The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a $7,748.14 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for INGREZZA 40 mg capsule 30-count units under firm fixed pricing. The order is placed against the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs...
- The Defense Logistics Agency issued a $3,874.06 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for INGREZZA 40 mg capsule 30-count units, with an ultimate completion date of March 24, 2026. The order is issued under the parent Indefinite Delivery Contract held by Cencora, Inc. (Amerisourcebergen's parent) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This vehicle supplies pharmaceutical products and medical commodities to support military...
- <p>The Defense Logistics Agency issued a $3,874.06 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for INGREZZA 40 MG capsules (30-count). The order was issued under the DLA Troop Support Medical IDC SPE2DX, a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price and an ultimate completion date of March 23, 2026.</p>
- <p>The Defense Logistics Agency issued a $3,874.06 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for INGREZZA 40 mg capsule (30-count units), with an ultimate completion date of March 20, 2026.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) with a contract ceiling value of $11,028.36. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for supply of INGREZZA 40 mg capsules (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a $7,352.24 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count) valued at $3,874.06 under a firm fixed-price contract. The award was issued on December 10, 2025, with an ultimate completion date of January 2, 2026. This non-set-aside delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle with the Defense Logistics Agency, with performance to occur at AmerisourceBergen's...
- SPE2DR25D2214Indefinite Delivery Contract
- SPE2DR25D2214-SPE2DR26FV9F6Delivery Order
The Defense Logistics Agency issued a $4,244.58 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for INGREZZA 80 mg capsule (30-count units) under firm fixed-price terms. The order has a completion date of March 26, 2026, and place of performance is Conshohocken, PA. This is a delivery order against the parent IDC held by Cencora, Inc. (parent organization of Amerisourcebergen Drug Corp) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. No set-aside was used for this order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 3/4/26 |